Tg(Thy1-APP*Swe*Ind)fAccu
Transgene Detail
|
Symbol: |
Tg(Thy1-APP*Swe*Ind)fAccu |
Name: |
transgene insertion f, A Claudio Cuello |
MGI ID: |
MGI:6324681 |
Synonyms: |
McGill-Thy1-APP Tg |
Transgene: |
Tg(Thy1-APP*Swe*Ind)fAccu Location: unknown
|
Alliance: |
Tg(Thy1-APP*Swe*Ind)fAccu page
|
|
Strain of Origin: |
(C3H x C57BL/6)F1
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Thy1-APP*Swe*Ind)fAccu expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APP (351) |
|
Contains the Swedish double mutation K670N and M671L and the Indiana mutation V717F |
|
|
|
Mutation details: The murine thymocyte antigen promotor (Thy1) drives the expression of the human APP (APP-751) cDNA bearing the Swedish double mutation K670N and M671L and the Indiana mutation V717F primarily in pyramidal neurons of the telencephalon and starting postnatally. Transgene copy number as assessed by Southern blotting is estimated to be about 20. Western blot analysis confirmed overexpression of the transgene in the hippocampus and cortex. Mice express on average 2-fold higher levels of amyloid beta42 than of amyloid beta40 in both cortex and hippocampus.
(J:251735)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:251735 Ferretti MT, et al., Transgenic mice as a model of pre-clinical Alzheimer's disease. Curr Alzheimer Res. 2011 Feb;8(1):4-23 |
All: |
4 reference(s) |
|